CD4 and mycosis fungoides: (3) Considering the atypical cerebriform morphology of the CD4+CD26− SS PBMCs expressing csPCNA [37,66,70], advanced studies are needed to evaluate the correlation between csPCNA expression and mAb14 in the biopsies and blood samples of patients with MF, and the treatment response and clinical parameters.